Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer (SNAC Study): An Observational Retrospective Multicenter Study With Matched Treatment Comparison

NCT06472063 is registered in ClinicalTrials.gov with San Luigi Gonzaga Hospital as lead sponsor.

NCT NCT06472063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer (SNAC Study): An Observational Retrospective Multicenter Study With Matched Treatment Comparison
Lead sponsor
San Luigi Gonzaga Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 22, 2022
Completion date
September 30, 2024
Enrollment
684 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer